• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mesenchymal stem cells-derived exosomes for drug delivery.间充质干细胞来源的外泌体用于药物递送。
Stem Cell Res Ther. 2021 Oct 30;12(1):561. doi: 10.1186/s13287-021-02629-7.
2
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases.间充质干细胞衍生的外泌体作为微 RNA 递药系统在不同疾病中的潜在应用。
Cell Commun Signal. 2023 Jan 23;21(1):20. doi: 10.1186/s12964-022-01017-9.
3
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials.临床研究中的间充质基质/干细胞(MSC)衍生的外泌体。
Stem Cell Res Ther. 2023 Apr 7;14(1):66. doi: 10.1186/s13287-023-03287-7.
4
Exosomes Secreted by Young Mesenchymal Stem Cells Promote New Bone Formation During Distraction Osteogenesis in Older Rats.年轻间充质干细胞分泌的外泌体在老年大鼠牵张成骨过程中促进新骨形成。
Calcif Tissue Int. 2020 May;106(5):509-517. doi: 10.1007/s00223-019-00656-4. Epub 2020 Feb 26.
5
Research progress of extracellular vesicles and exosomes derived from mesenchymal stem cells in the treatment of oxidative stress-related diseases.间充质干细胞来源的细胞外囊泡和外泌体在治疗氧化应激相关疾病中的研究进展。
Front Immunol. 2023 Aug 14;14:1238789. doi: 10.3389/fimmu.2023.1238789. eCollection 2023.
6
Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases.间充质干细胞衍生的外泌体对自身免疫性疾病的影响。
Front Immunol. 2021 Sep 27;12:749192. doi: 10.3389/fimmu.2021.749192. eCollection 2021.
7
Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.当去甲斑蝥素被封装在骨髓间充质干细胞衍生的外泌体中时,肝细胞癌的治疗效果得到增强。
Mol Pharm. 2021 Mar 1;18(3):1003-1013. doi: 10.1021/acs.molpharmaceut.0c00976. Epub 2021 Feb 2.
8
Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases.脂肪组织源间充质干细胞衍生的外泌体在神经和视网膜疾病治疗中的治疗潜力。
Int J Mol Sci. 2022 Apr 19;23(9):4487. doi: 10.3390/ijms23094487.
9
Dual impacts of mesenchymal stem cell-derived exosomes on cancer cells: unravelling complex interactions.间充质干细胞衍生外泌体对癌细胞的双重影响:揭示复杂的相互作用
J Cell Commun Signal. 2023 Dec;17(4):1229-1247. doi: 10.1007/s12079-023-00794-3. Epub 2023 Nov 16.
10
Compounding engineered mesenchymal stem cell-derived exosomes: A potential rescue strategy for retinal degeneration.工程化间充质干细胞衍生外泌体的制备:视网膜变性的潜在挽救策略。
Biomed Pharmacother. 2024 Apr;173:116424. doi: 10.1016/j.biopha.2024.116424. Epub 2024 Mar 11.

引用本文的文献

1
Exosomes derived from human umbilical cord mesenchymal stem cells attenuate hepatic ischaemia-reperfusion injury the let-7i-5p/Faslg axis.源自人脐带间充质干细胞的外泌体通过let-7i-5p/Faslg轴减轻肝脏缺血再灌注损伤
World J Gastroenterol. 2025 Sep 7;31(33):108653. doi: 10.3748/wjg.v31.i33.108653.
2
Stem cell extracellular vesicles: a new dawn for anti-inflammatory treatment of neurodegenerative diseases.干细胞外泌体:神经退行性疾病抗炎治疗的新曙光。
Front Aging Neurosci. 2025 Jul 11;17:1592578. doi: 10.3389/fnagi.2025.1592578. eCollection 2025.
3
Natural carrier systems in cancer vaccines and immunotherapy.癌症疫苗和免疫疗法中的天然载体系统。
Hum Vaccin Immunother. 2025 Dec;21(1):2535787. doi: 10.1080/21645515.2025.2535787. Epub 2025 Jul 24.
4
Revolutionizing cancer treatment: engineering mesenchymal stem cell-derived small extracellular vesicles.变革癌症治疗:工程化间充质干细胞衍生的小细胞外囊泡
Cancer Cell Int. 2025 Jul 21;25(1):275. doi: 10.1186/s12935-025-03900-0.
5
Mesenchymal stem cell-derived exosomes and the Wnt/β-catenin pathway: Unifying mechanisms of multi-organ regeneration and the path to precision clinical translation.间充质干细胞衍生的外泌体与Wnt/β-连环蛋白信号通路:多器官再生的统一机制及精准临床转化之路
World J Stem Cells. 2025 Jun 26;17(6):106902. doi: 10.4252/wjsc.v17.i6.106902.
6
Mesenchymal stem cell-derived exosomes-a promising therapeutic approach to improve neurocognitive disorders in chronic obstructive pulmonary disease.间充质干细胞衍生的外泌体——一种改善慢性阻塞性肺疾病神经认知障碍的有前景的治疗方法。
Stem Cell Res Ther. 2025 Jun 20;16(1):314. doi: 10.1186/s13287-025-04457-5.
7
Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model.间充质干细胞衍生外泌体治疗膝骨关节炎:基于大鼠模型的系统评价和荟萃分析
Front Pharmacol. 2025 Jun 2;16:1588841. doi: 10.3389/fphar.2025.1588841. eCollection 2025.
8
Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects.树突状细胞衍生的外泌体作为无细胞抗癌剂:增强免疫原性作用的新见解
Front Immunol. 2025 May 28;16:1586892. doi: 10.3389/fimmu.2025.1586892. eCollection 2025.
9
Mechanism-based nonopioid analgesic targets.基于机制的非阿片类镇痛靶点。
J Clin Invest. 2025 Jun 2;135(11). doi: 10.1172/JCI191346.
10
Extracellular Vesicle-Based Drug Delivery Systems in Cancer Therapy.基于细胞外囊泡的癌症治疗药物递送系统
Int J Mol Sci. 2025 May 19;26(10):4835. doi: 10.3390/ijms26104835.

本文引用的文献

1
Mesenchymal stem cell-derived exosomes: a promising vector in treatment for diabetes and its microvascular complications.间充质干细胞衍生的外泌体:治疗糖尿病及其微血管并发症的一种有前景的载体。
Am J Transl Res. 2021 May 15;13(5):3942-3953. eCollection 2021.
2
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications.间充质干细胞外泌体作为治疗糖尿病并发症的新策略。
Front Endocrinol (Lausanne). 2021 Apr 29;12:646233. doi: 10.3389/fendo.2021.646233. eCollection 2021.
3
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1.间充质干细胞来源的外泌体携带微小RNA-125a,通过靶向组蛋白去乙酰化酶1并下调内皮素-1来预防糖尿病肾病。
Diabetes Metab Syndr Obes. 2021 Mar 25;14:1405-1418. doi: 10.2147/DMSO.S286191. eCollection 2021.
4
Current advances and challenges of mesenchymal stem cells-based drug delivery system and their improvements.基于间充质干细胞的药物递送系统的最新进展、挑战及改进。
Int J Pharm. 2021 May 1;600:120477. doi: 10.1016/j.ijpharm.2021.120477. Epub 2021 Mar 16.
5
Mesenchymal Stem Cell exosome delivered Zinc Finger Protein activation of cystic fibrosis transmembrane conductance regulator.间充质干细胞外泌体传递锌指蛋白激活囊性纤维化跨膜电导调节因子。
J Extracell Vesicles. 2021 Jan;10(3):e12053. doi: 10.1002/jev2.12053. Epub 2021 Jan 23.
6
Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.当去甲斑蝥素被封装在骨髓间充质干细胞衍生的外泌体中时,肝细胞癌的治疗效果得到增强。
Mol Pharm. 2021 Mar 1;18(3):1003-1013. doi: 10.1021/acs.molpharmaceut.0c00976. Epub 2021 Feb 2.
7
'Golden' exosomes as delivery vehicles to target tumors and overcome intratumoral barriers: in vivo tracking in a model for head and neck cancer.“金色”外泌体作为靶向肿瘤并克服肿瘤内屏障的递送载体:在头颈癌模型中的体内追踪
Biomater Sci. 2021 Mar 21;9(6):2103-2114. doi: 10.1039/d0bm01735c. Epub 2021 Jan 21.
8
Advances in mesenchymal stem cell exosomes: a review.间质干细胞外泌体的研究进展:综述。
Stem Cell Res Ther. 2021 Jan 19;12(1):71. doi: 10.1186/s13287-021-02138-7.
9
Delivery of miR-381-3p Mimic by Mesenchymal Stem Cell-Derived Exosomes Inhibits Triple Negative Breast Cancer Aggressiveness; an In Vitro Study.间充质干细胞来源的外泌体递送 miR-381-3p 模拟物抑制三阴性乳腺癌侵袭性;一项体外研究。
Stem Cell Rev Rep. 2021 Jun;17(3):1027-1038. doi: 10.1007/s12015-020-10089-4. Epub 2021 Jan 6.
10
Exosomal miR-499a-5p Inhibits Endometrial Cancer Growth and Metastasis via Targeting VAV3.外泌体miR-499a-5p通过靶向VAV3抑制子宫内膜癌的生长和转移。
Cancer Manag Res. 2020 Dec 31;12:13541-13552. doi: 10.2147/CMAR.S283747. eCollection 2020.

间充质干细胞来源的外泌体用于药物递送。

Mesenchymal stem cells-derived exosomes for drug delivery.

机构信息

Department of General Surgery, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun, 130041, China.

Operating Theater and Department of Anestheology, The Second Hospital of Jilin University, Changchun, 130041, China.

出版信息

Stem Cell Res Ther. 2021 Oct 30;12(1):561. doi: 10.1186/s13287-021-02629-7.

DOI:10.1186/s13287-021-02629-7
PMID:34717769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8557580/
Abstract

Exosomes are extracellular vesicles secreted by various cells, mainly composed of lipid bilayers without organelles. In recent years, an increasing number of researchers have focused on the use of exosomes for drug delivery. Targeted drug delivery in the body is a promising method for treating many refractory diseases such as tumors and Alzheimer's disease (AD). Finding a suitable drug delivery carrier in the body has become a popular research today. In various drug delivery studies, the exosomes secreted by mesenchymal stem cells (MSC-EXOs) have been broadly researched due to their immune properties, tumor-homing properties, and elastic properties. While MSC-EXOs have apparent advantages, some unresolved problems also exist. This article reviews the studies on MSC-EXOs for drug delivery, summarizes the characteristics of MSC-EXOs, and introduces the primary production and purification methods and drug loading methods to provide solutions for existing problems and suggestions for future studies.

摘要

外泌体是由各种细胞分泌的细胞外囊泡,主要由无细胞器的脂质双层组成。近年来,越来越多的研究人员关注将外泌体用于药物递送。在体内进行靶向药物递送是治疗肿瘤和阿尔茨海默病(AD)等许多难治性疾病的有前途的方法。在体内寻找合适的药物递送载体已成为当今热门的研究领域。在各种药物递送研究中,由于间充质干细胞(MSC-EXOs)分泌的外泌体具有免疫特性、肿瘤归巢特性和弹性特性,因此受到广泛研究。虽然 MSC-EXOs 具有明显的优势,但也存在一些尚未解决的问题。本文综述了用于药物递送的 MSC-EXOs 的研究,总结了 MSC-EXOs 的特性,介绍了主要的生产和纯化方法以及药物加载方法,为现有问题提供了解决方案,并对未来的研究提出了建议。